DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient PatientsMaria Grazia Castagna, Domenico Salvatore, Carlotta Marzocchi et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 155
SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinomaElena Abbotto, Santina Bruzzone, Caterina Miro et al.|Biomedicine & Pharmacotherapy|2023Cited by 12
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological AssaysFrancesco Piacente, Enrico Millo, Giorgia Guccione et al.|International Journal of Molecular Sciences|2024Cited by 4